Evidence map›Paper›PMID 32983469›Full record

ArticleClinical case reports2020

Uncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report.

Mrinal Gupta, Paul S Yamauchi, Martine Bagot, Jacek Szepietowski, Shibani Bhatia, Torello Lotti, Mohamad Goldust

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 9 countries.

Mrinal GuptaTreatwell Skin Centre Jammu India.
Paul S YamauchiDermatology Institute and Skin Care Center Santa Monica California USA.
Martine BagotAP-HP Dermatology Department Saint-Louis Hospital INSERM U976 Université Paris Diderot-Paris VII Sorbonne Paris Cité Paris France.
Jacek SzepietowskiDepartment of Dermatology, Venereology and Allergology Wroclaw Medical University Wroclaw Poland.
Shibani BhatiaDepartment of Dermatology, Venereology and Leprosy Kasturba medical college Manipal Manipal Academy of Higher Education Manipal India.
Torello LottiUniversity of Studies Guglielmo Marconi Rome Italy.
Mohamad GoldustMazandaran University of Medical Sciences Sari Iran.ORCID https://orcid.org/0000-0003-1085-9401
Inserm · FRJohannes Gutenberg University Mainz · DEManipal Academy of Higher Education · INMarconi University · ITUniversity of California, Los Angeles · USUniversity of Jammu · INWroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recombinant interferon beta-1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea.

Indexed as

interferon beta‐1bmorpheamultiple sclerosis

Identifiers

PMID32983469
PMCPMC7495805
OpenAlexW3029585696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.